Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.060
-0.090 (-7.83%)
At close: Oct 13, 2025, 4:00 PM EDT
1.030
-0.030 (-2.83%)
Pre-market: Oct 14, 2025, 7:13 AM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $13.82 million as of October 14, 2025. Its market cap has decreased by -20.56% in one year.
Market Cap
13.82M
Enterprise Value
10.71M
1-Year Change
-20.56%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $13.82M, a decrease of -88.01%. That is a compound annual growth rate of -24.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 10.90M | -47.09% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |